Related Experiment Video
Updated: Aug 18, 2026

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine
Published on: February 17, 2018
Lessons from the management of chronic heart failure
1Royal Brompton & Harefield NHS Trust, Sydney Street, London SW3 6NP, UK. t.mcdonagh@imperial.ac.uk
Insights
Evidence-based medicine for heart failure after myocardial infarction (MI) can improve outcomes. Learning from chronic heart failure (CHF) care, multidisciplinary programs enhance treatment adherence and reduce hospitalizations.
Area of Science:
- Cardiology
- Evidence-Based Medicine
- Heart Failure Management
Background:
- Heart failure following myocardial infarction (MI) shares a continuum with chronic heart failure (CHF) due to left ventricular systolic dysfunction.
- Established evidence supports angiotensin converting enzyme inhibitors, beta blockers, and aldosterone antagonists for improving morbidity and mortality in heart failure patients.
- Despite guideline development, low treatment uptake in registries prompted research into more effective heart failure care delivery.
Purpose of the Study:
- To explore the application of lessons learned from chronic heart failure management to the care of patients with heart failure post-myocardial infarction.
- To highlight the importance of evidence-based medicine in optimizing cardiovascular care.
Main Methods:
- Review of evidence supporting pharmacological interventions (ACE inhibitors, beta blockers, aldosterone antagonists).
- Analysis of registry data on treatment uptake and heart failure management programs.
- Examination of the impact of multidisciplinary heart failure management programs on patient outcomes.
Main Results:
- Multidisciplinary heart failure management programs have demonstrated reductions in hospital admission rates and improved treatment adherence.
- These programs, spanning primary and secondary care, are recognized as a standard for effective chronic heart failure care.
Conclusions:
- Applying multidisciplinary management programs, proven effective for chronic heart failure, is crucial for optimizing care in post-myocardial infarction heart failure patients.
- Integrating evidence-based medicine and structured management programs can improve outcomes for patients across the cardiovascular continuum.
Abstract:
In seeking to implement evidence based medicine for the patient with heart failure occurring after a myocardial infarction (MI), much can be learnt from the long road to delivery of best care for the patient with chronic heart failure (CHF) caused by left ventricular systolic dysfunction. Both patient groups are part of the same cardiovascular continuum. A mass of evidence has accrued for the beneficial effects of angiotensin converting enzyme inhibitors, beta blockers, and aldosterone antagonists on both morbidity and mortality across a wide spectrum of patient severity. This evidence has informed the development of management guidelines, although registry data showed that uptake of treatments remained low, leading to research focused on how heart failure care could be delivered more effectively. This has resulted in a range of heart failure management programmes, many of which have been shown to reduce hospital admission rates and to improve adherence with treatments. Multidisciplinary heart failure management programmes that span primary and secondary care are now considered a routine "standard" to be aspired to in delivering effective CHF care. Applying such an approach to the care of the post-MI heart failure patient should be equally important.
More Related Videos
Related Concept Videos
Mitral Regurgitation IV: Nursing Management
Rheumatic Heart Disease III: Medical Management
Heart Failure V: Medical Management
Heart Failure VI: Adjunct Therapies
Heart Failure VII: Nursing Interventions
Cardiomyopathy VI: Nursing Management

